These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 8029801

  • 1. A comparative study of prothrombinase and thrombin inhibitors in a novel rabbit model of non-occlusive deep vein thrombosis.
    Hollenbach S, Sinha U, Lin PH, Needham K, Frey L, Hancock T, Wong A, Wolf D.
    Thromb Haemost; 1994 Mar; 71(3):357-62. PubMed ID: 8029801
    [Abstract] [Full Text] [Related]

  • 2. Antithrombotic and hemostatic capacity of factor Xa versus thrombin inhibitors in models of venous and arteriovenous thrombosis.
    Sinha U, Ku P, Malinowski J, Zhu BY, Scarborough RM, Marlowe CK, Wong PW, Lin PH, Hollenbach SJ.
    Eur J Pharmacol; 2000 Apr 21; 395(1):51-9. PubMed ID: 10781674
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Active site-blocked factor Xa prevents thrombus formation in the coronary vasculature in parallel with inhibition of extravascular coagulation in a canine thrombosis model.
    Benedict CR, Ryan J, Todd J, Kuwabara K, Tijburg P, Cartwright J, Stern D.
    Blood; 1993 Apr 15; 81(8):2059-66. PubMed ID: 8471766
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of AR-H067637, the active metabolite of the new direct thrombin inhibitor AZD0837, in models of venous and arterial thrombosis and bleeding in anaesthetised rats.
    Pehrsson S, Johansson K, Kjaer M, Elg M.
    Thromb Haemost; 2010 Dec 15; 104(6):1242-9. PubMed ID: 20806126
    [Abstract] [Full Text] [Related]

  • 6. The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparin.
    Buchanan MR, Boneu B, Ofosu F, Hirsh J.
    Blood; 1985 Jan 15; 65(1):198-201. PubMed ID: 3965047
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antithrombotic efficacy of thrombin inhibitor L-374,087: intravenous activity in a primate model of venous thrombus extension and oral activity in a canine model of primary venous and coronary artery thrombosis.
    Cook JJ, Gardell SJ, Holahan MA, Sitko GR, Stump GL, Wallace AA, Gilberto DB, Hare TR, Krueger JA, Dyer DL, Sanderson PE, Vacca JP, Shafer JA, Lynch JJ.
    J Pharmacol Exp Ther; 1999 Apr 15; 289(1):503-10. PubMed ID: 10087043
    [Abstract] [Full Text] [Related]

  • 9. Antithrombotic and anticoagulant profiles of TAK-442, a novel factor Xa inhibitor, in a rabbit model of venous thrombosis.
    Kawamura M, Konishi N, Hiroe K, Shofuda K, Imaeda Y, Fujimoto T, Kubo K.
    J Cardiovasc Pharmacol; 2010 Aug 15; 56(2):156-61. PubMed ID: 20410831
    [Abstract] [Full Text] [Related]

  • 10. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
    Melo FR, Mourão PA.
    Thromb Haemost; 2008 Mar 15; 99(3):531-8. PubMed ID: 18327401
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Razaxaban, a direct factor Xa inhibitor, in combination with aspirin and/or clopidogrel improves low-dose antithrombotic activity without enhancing bleeding liability in rabbits.
    Wong PC, Crain EJ, Watson CA, Wexler RR, Lam PY, Quan ML, Knabb RM.
    J Thromb Thrombolysis; 2007 Aug 15; 24(1):43-51. PubMed ID: 17323133
    [Abstract] [Full Text] [Related]

  • 13. The importance of enzyme inhibition kinetics for the effect of thrombin inhibitors in a rat model of arterial thrombosis.
    Elg M, Gustafsson D, Deinum J.
    Thromb Haemost; 1997 Oct 15; 78(4):1286-92. PubMed ID: 9364999
    [Abstract] [Full Text] [Related]

  • 14. Thrombin inhibitors and anti-coagulants on thrombin-induced embolisation in rabbit cranial vasculature.
    Liu JT, Paul W, Emerson M, Cicala C, Page CP.
    Eur J Pharmacol; 1994 Oct 24; 264(2):183-90. PubMed ID: 7851481
    [Abstract] [Full Text] [Related]

  • 15. Low molecular weight heparins prevent thrombin-induced thrombo-embolism in mice despite low anti-thrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition.
    Momi S, Nasimi M, Colucci M, Nenci GG, Gresele P.
    Haematologica; 2001 Mar 24; 86(3):297-302. PubMed ID: 11255277
    [Abstract] [Full Text] [Related]

  • 16. Antithrombotic potential of GW813893: a novel, orally active, active-site directed factor Xa inhibitor.
    Abboud MA, Needle SJ, Burns-Kurtis CL, Valocik RE, Koster PF, Amour AJ, Chan C, Brown D, Chaudry L, Zhou P, Patikis A, Patel C, Pateman AJ, Young RJ, Watson NS, Toomey JR.
    J Cardiovasc Pharmacol; 2008 Jul 24; 52(1):66-71. PubMed ID: 18645410
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological effects of a novel recombinant hirudin, CX-397, in vivo and in vitro: comparison with recombinant hirudin variant-1, heparin, and argatroban.
    Komatsu Y, Inoue Y, Goto Y, Fukazawa T, Hayashi H.
    Thromb Haemost; 1999 Feb 24; 81(2):250-5. PubMed ID: 10064001
    [Abstract] [Full Text] [Related]

  • 18. Nonpeptide factor Xa inhibitors III: effects of DPC423, an orally-active pyrazole antithrombotic agent, on arterial thrombosis in rabbits.
    Wong PC, Crain EJ, Watson CA, Zaspel AM, Wright MR, Lam PY, Pinto DJ, Wexler RR, Knabb RM.
    J Pharmacol Exp Ther; 2002 Dec 24; 303(3):993-1000. PubMed ID: 12438519
    [Abstract] [Full Text] [Related]

  • 19. Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis model.
    Biemond BJ, Levi M, Nurmohamed MT, Büller HR, ten Cate JW.
    Thromb Haemost; 1994 Sep 24; 72(3):377-80. PubMed ID: 7855787
    [Abstract] [Full Text] [Related]

  • 20. Comparison of thrombin active site and exosite inhibitors and heparin in experimental models of arterial and venous thrombosis and bleeding.
    Schumacher WA, Steinbacher TE, Heran CL, Seiler SM, Michel IM, Ogletree ML.
    J Pharmacol Exp Ther; 1993 Dec 24; 267(3):1237-42. PubMed ID: 8263785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.